bioAffinity Technologies (BIAF) Short Interest Ratio & Short Volume → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free BIAF Stock Alerts $2.37 -0.04 (-1.66%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media bioAffinity Technologies Short Interest DataCurrent Short Volume240,900 sharesPrevious Short Volume55,100 sharesChange Vs. Previous Month+337.21%Dollar Volume Sold Short$664,884.00Short Interest Ratio / Days to Cover1.1Last Record DateApril 15, 2024Outstanding Shares11,510,000 sharesFloat Size5,540,000 sharesShort Percent of Float4.35%Today's Trading Volume94,849 sharesAverage Trading Volume201,345 sharesToday's Volume Vs. Average47% Short Selling bioAffinity Technologies ? Sign up to receive the latest short interest report for bioAffinity Technologies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBIAF Short Interest Over TimeBIAF Days to Cover Over TimeBIAF Percentage of Float Shorted Over Time Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. bioAffinity Technologies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024240,900 shares $664,884.00 +337.2%4.4%1.1 $2.76 3/31/202455,100 shares $111,302.00 -12.1%1.3%0.3 $2.02 3/15/202462,700 shares $119,130.00 +148.8%1.8%0.4 $1.90 2/29/202425,200 shares $58,464.00 +159.8%0.7%0.2 $2.32 2/15/20249,700 shares $14,647.00 +73.2%0.3%0.4 $1.51 1/31/20245,600 shares $8,792.00 -60.6%0.2%0.4 $1.57 Get the Latest News and Ratings for BIAF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for bioAffinity Technologies and its competitors with MarketBeat's FREE daily newsletter. 1/15/202414,200 shares $21,158.00 -47.6%0.4%1 $1.49 12/31/202327,100 shares $39,850.55 -45.3%0.7%2 $1.47 12/15/202349,500 shares $76,230.00 +32.4%1.3%3.5 $1.54 11/30/202337,400 shares $62,084.00 -17.8%1.0%3 $1.66 11/15/202345,500 shares $64,382.50 -2.2%1.2%5.6 $1.42 10/31/202346,500 shares $58,664.40 -7.7%1.3%6 $1.26 10/15/202350,400 shares $66,900.96 +39.6%1.4%5.7 $1.33 9/30/202336,100 shares $42,013.18 -43.9%1.1%3.3 $1.16 9/15/202364,300 shares $108,667.00 +7.4%1.7%5.8 $1.69 8/31/202359,900 shares $103,627.00 -9.5%1.7%5.1 $1.73 8/15/202366,200 shares $122,801.00 -5.2%1.8%4.7 $1.86 7/31/202369,800 shares $122,848.00 -7.4%1.9%4.7 $1.76 7/15/202375,400 shares $133,458.00 -10.2%2.1%4.5 $1.77 6/30/202384,000 shares $153,720.00 +7.4%2.3%4.5 $1.83 6/15/202378,200 shares $139,978.00 +22.8%2.1%3.6 $1.79 5/31/202363,700 shares $116,571.00 -0.6%1.7%2.9 $1.83 5/15/202364,100 shares $116,662.00 No Change1.2%1.9 $1.82 BIAF Short Interest - Frequently Asked Questions What is bioAffinity Technologies' current short interest? Short interest is the volume of bioAffinity Technologies shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 240,900 shares of BIAF short. 4.35% of bioAffinity Technologies' shares are currently sold short. Learn More on bioAffinity Technologies' current short interest. What is a good short interest ratio for bioAffinity Technologies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BIAF shares currently have a short interest ratio of 1.0. Learn More on bioAffinity Technologies's short interest ratio. What is a good short interest percentage for bioAffinity Technologies? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.35% of bioAffinity Technologies' floating shares are currently sold short. Is bioAffinity Technologies' short interest increasing or decreasing? bioAffinity Technologies saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 240,900 shares, an increase of 337.2% from the previous total of 55,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is bioAffinity Technologies' float size? bioAffinity Technologies currently has issued a total of 11,510,000 shares. Some of bioAffinity Technologies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. bioAffinity Technologies currently has a public float of 5,540,000 shares. How does bioAffinity Technologies' short interest compare to its competitors? 4.35% of bioAffinity Technologies' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to bioAffinity Technologies: Daré Bioscience, Inc. (0.25%), NeuroOne Medical Technologies Co. (1.40%), NRx Pharmaceuticals, Inc. (6.69%), MiNK Therapeutics, Inc. (0.49%), Femasys Inc. (5.84%), Aprea Therapeutics, Inc. (2.01%), Singular Genomics Systems, Inc. (1.42%), Lexaria Bioscience Corp. (3.70%), Spruce Biosciences, Inc. (0.74%), Surrozen, Inc. (1.89%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short bioAffinity Technologies stock? Short selling BIAF is an investing strategy that aims to generate trading profit from bioAffinity Technologies as its price is falling. BIAF shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against bioAffinity Technologies? A short squeeze for bioAffinity Technologies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIAF, which in turn drives the price of the stock up even further. How often is bioAffinity Technologies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIAF, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Daré Bioscience Short Interest Data NeuroOne Medical Technologies Short Interest Data NRx Pharmaceuticals Short Interest Data MiNK Therapeutics Short Interest Data Femasys Short Interest Data Aprea Therapeutics Short Interest Data Singular Genomics Systems Short Interest Data Lexaria Bioscience Short Interest Data Spruce Biosciences Short Interest Data Surrozen Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BIAF) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithProtect Your Bank Account Before It’s Too LateWeiss RatingsBiden out June 13; Kamala won’t replace him?Paradigm PressThe World's First "$20 Trillion Drug?"Behind the Markets